AU2002300457A1 - Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies - Google Patents

Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies

Info

Publication number
AU2002300457A1
AU2002300457A1 AU2002300457A AU2002300457A AU2002300457A1 AU 2002300457 A1 AU2002300457 A1 AU 2002300457A1 AU 2002300457 A AU2002300457 A AU 2002300457A AU 2002300457 A AU2002300457 A AU 2002300457A AU 2002300457 A1 AU2002300457 A1 AU 2002300457A1
Authority
AU
Australia
Prior art keywords
monoclonal antibodies
antibody fragment
humanized anti
polymer conjugates
conjugates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002300457A
Other versions
AU2002300457B2 (en
Inventor
Vanessa Hsei
Iphigenia Koumenis
Steven R Leong
Leonard G Presta
Zahra Shahrokh
Gerardo A Zapata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU65357/98A external-priority patent/AU746819B2/en
Application filed by Genentech Inc filed Critical Genentech Inc
Priority to AU2002300457A priority Critical patent/AU2002300457B2/en
Priority claimed from AU2002300457A external-priority patent/AU2002300457B2/en
Publication of AU2002300457A1 publication Critical patent/AU2002300457A1/en
Application granted granted Critical
Publication of AU2002300457B2 publication Critical patent/AU2002300457B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002300457A 1997-02-21 2002-08-02 Antibody Fragment-Polymer Conjugates and Humanized Anti-IL-8 Monoclonal Antibodies Ceased AU2002300457B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002300457A AU2002300457B2 (en) 1997-02-21 2002-08-02 Antibody Fragment-Polymer Conjugates and Humanized Anti-IL-8 Monoclonal Antibodies

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/804444 1997-02-21
US09/012116 1998-01-22
AU65357/98A AU746819B2 (en) 1997-02-21 1998-02-20 Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies
AU2002300457A AU2002300457B2 (en) 1997-02-21 2002-08-02 Antibody Fragment-Polymer Conjugates and Humanized Anti-IL-8 Monoclonal Antibodies

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU65357/98A Division AU746819B2 (en) 1997-02-21 1998-02-20 Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies

Publications (2)

Publication Number Publication Date
AU2002300457A1 true AU2002300457A1 (en) 2003-02-13
AU2002300457B2 AU2002300457B2 (en) 2005-09-01

Family

ID=39277053

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002300457A Ceased AU2002300457B2 (en) 1997-02-21 2002-08-02 Antibody Fragment-Polymer Conjugates and Humanized Anti-IL-8 Monoclonal Antibodies

Country Status (1)

Country Link
AU (1) AU2002300457B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116183899B (en) * 2023-04-28 2023-06-30 天津市协和医药科技集团有限公司 Preparation method of acridinium ester marked antibody preservation solution

Similar Documents

Publication Publication Date Title
AU2559799A (en) Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies and uses of same
AU4042195A (en) Anti-alphaV-integrin monoclonal antibody
AU8432498A (en) Human-cd28 specific monoclonal antibodies for antigen non-specific activation oft-lymphocytes
AU1462300A (en) Human pan-hcv human monoclonal antibodies
IL128406A0 (en) Monoclonal antibodies
AU1704099A (en) Monoclonal human natural antibodies
AU7863794A (en) Antihuman tyrosinase monoclonal antibody
AU5869596A (en) Anti-gp130 monoclonal antibodies
EP0870826A4 (en) Novel protein and monoclonal antibody specific thereto
AU1687500A (en) Antihuman vegf monoclonal antibody
IL147517A0 (en) Monoclonal antibodies and immunoassay utilizing the same
AU6702998A (en) Anti-alphabeta3 humanized monoclonal antibodies
AU4441799A (en) Monoclonal antibodies that recognize antigens associated with tumor metastasis
AU5441000A (en) Human monoclonal antibody
AU7072998A (en) Immunoassays using anti-allotypic monoclonal antibodies
AU2645297A (en) Hepatitis b monoclonal antibodies
AU5937598A (en) Humanized anti-human Fas antibody
AU2596397A (en) Monoclonal antibody that detects apoptotic antigen
AU3923293A (en) Human monoclonal antibodies and methods for human monoclonal antibody production
IL138022A0 (en) High affinity humanized anti-cea monoclonal antibodies
AU2759899A (en) Purified sperm surface antigen, monoclonal antibody therefor and application therefor
AU7690496A (en) Monoclonal antiidiotypic antibodies (AB2) and their uses
AU2002300457A1 (en) Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies
AU3079895A (en) Immunonanoparticles coated with anti-beta-2 microglobulin monoclonal antibodies
ZA99319B (en) Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies and uses of same.